Psychiatry
Volume 5, Issue 5 , Pages 162-166, 1 May 2006

Pharmacology of drugs used in the treatment of mood disorders

  • Sarah Gartside, BSc DPhil

      Affiliations

    • Sarah Gartside BSc DPhil is Lecturer in the School of Neurology, Neurobiology and Psychiatry at Newcastle University, UK. Her research interests include effects of antidepressants on brain 5-HT systems and interactions between the HPA axis and 5-HT function.
    • ,
  • Philip Cowen, MD FRCPsych FMedSci

      Affiliations

    • Philip Cowen MD FRCPsych FMedSci is Professor of Psychopharmacology and MRC Clinical Scientist in the Department of Psychiatry at the University of Oxford, UK. His main interest is in the biochemistry of mood disorders.

Abstract 

The pharmacological treatment of mood disorders remains focused around the use of monoamine potentiating agents for the management of depression. There are, however, a growing number of agents available for management of bipolar disorder, with both anticonvulsants and atypical antipsychotic drugs showing promise in the management of bipolar depression.

Keywords:  mood disorder , anticonvulsant , antidepressant , atypical antipsychotic , bipolar disorder , depression , mania-resistant depression , mood stabiliser , noradrenaline , serotonin (5-HT) , SNRI , SSRI

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1476-1793(06)70036-2

doi:10.1383/psyt.2006.5.5.162

Psychiatry
Volume 5, Issue 5 , Pages 162-166, 1 May 2006

Article Tools